B of A Securities Downgrades PROCEPT BioRobotics to Neutral, Lowers Price Target to $38
Benzinga Newsdesk 11 months ago
NewsDowngradesPrice TargetAnalyst Ratings
B of A Securities analyst Craig Bijou downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Buy to Neutral and lowers the price target from $55 to $38.
B of A Securities analyst Craig Bijou downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Buy to Neutral and lowers the price target from $55 to $38.